loader

pancreatic cancer

LATEST ARTICLES

Rexahn Reports First Quarter 2018 Financial Results

Shire plc : Shire Announces Sale of Oncology Business to Servier for $2.4 Billion

Tyme Provides Clinical and Corporate Update for Fiscal Year End 2018

Bio-Path Holdings Reports Full Year 2017 Financial Results

pharmaceutical investing

Rexahn Pharmaceuticals Reports Full Year 2017 Financial Results

Tyme Provides Clinical and Corporate Update for Fiscal Third Quarter 2017

Sun Biopharma Announces Initiation of First-Line Combination Study

pharmaceutical investing

ChemoCentryx Announces Positive Overall Survival Results with CCR2 Inhibitor CCX872

pharmaceutical investing

Propanc Biopharma Highlights Therapeutic Potential of PRP

PharmaCyte Biotech Appoints New Chief Medical Officer

pharmaceutical investing

Propanc Biopharma Receives Orphan Drug Designation from FDA

pharmaceutical investing

Moleculin Discovers Potential Treatment of Pancreatic Cancer

Latest News

More News